Autolus Therapeutics (AUTL) News
NASDAQ: AUTLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.9073-0.0723 (-7.38%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AUTL news summary
We found 7 recent headlines mentioning Autolus Therapeutics (AUTL): 0 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Nasdaq. AUTL is making an outsized move today, down 7.38% at $0.9073, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Autolus (AUTL) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Autolus Therapeutics headlines
- Autolus (AUTL) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Autolus Therapeutics Presents Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026Autolus announced data from the ongoing CARLYSLE trial, a Phase 1 clinical trial of obe-cel in severe refractory systemic lupus erythematosus.GlobeNewswire
- Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business UpdatesAutolus reports third quarter 2026 financial results, including AUCATZYL net product revenue and guidance, and pipeline updates.GlobeNewswire
- Autolus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceAutolus will present at the Jefferies Global Healthcare Conference on November 17, 2026 in London.GlobeNewswire
- Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026Autolus announced the online publication of abstracts submitted to the American Society of Hematology (ASH) Annual Meeting.GlobeNewswire
- Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Autolus awards inducement grant stock options.GlobeNewswire
- Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026Autolus will report Q3 2026 financial results on November 10, 2026.GlobeNewswire